Articles Tagged With: Mifepristone
-
FDA Updates Mifepristone Labeling, Easing Access to Abortion Pill
The Food and Drug Administration has approved new and updated labeling for the medication abortion drug mifepristone (Mifeprex, Danco Laboratories, New York City) to reflect the most current clinical practices and safety and efficacy data. The drug’s new label reduces the size of the initial dose and extends the window for taking it to 70 days since the first day of a woman’s last menstrual period.
-
‘Graying’ providers: Will abortion care be limited?
-
Abortion pill advisory issued
-
FDA gives nod to label change for misoprostol
-
Mifepristone approval delayed, supporters look to action by FDA